<DOC>
	<DOCNO>NCT00444717</DOCNO>
	<brief_summary>The purpose study evaluate anti-oxidative anti-inflammatory effect pitavastatin hypercholesterolemic patient metabolic syndrome .</brief_summary>
	<brief_title>Impact Pitavastatin Hypercholesterolemic Patients With Metabolic Syndrome</brief_title>
	<detailed_description>The metabolic syndrome define cluster cardiovascular risk factor include visceral obesity , dyslipidemia , elevate blood pressure impair glucose tolerance . Recently , describe oxidative stress inflammatory reaction , important progression atherosclerosis , increase individual metabolic syndrome . Statins might beneficial effect anti-oxidative anti-inflammatory action independent cholesterol-lowering effect . Pitavastatin , chemically synthesize statin , potent LDL-cholesterol lowering also anti-oxidative anti-inflammatory effect animal study . However , effect pitavastatin oxidative stress inflammatory action patient metabolic syndrome report .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Hypercholesterolemic patient Patients receive lipidlowering agent Familial hypercholesterolemia Renal disease Diseases liver , gallbladder bile duct Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>statin</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>inflammation</keyword>
</DOC>